Equities research analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued to clients and investors on Wednesday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Price Performance
NASDAQ SRNE opened at $0.01 on Wednesday. The business has a fifty day simple moving average of $0.01 and a 200 day simple moving average of $0.03. Sorrento Therapeutics has a 12 month low of $0.00 and a 12 month high of $0.42.
Sorrento Therapeutics Company Profile
Featured Stories
- Five stocks we like better than Sorrento Therapeutics
- How to Calculate Inflation Rate
- Sales Breakout Sends This Semiconductor Stock to Record High
- Earnings Per Share Calculator: How to Calculate EPS
- Surprise Buying Opportunity on This Dividend Aristocrat
- The Significance of Brokerage Rankings in Stock Selection
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.